Product logins

Find logins to all Clarivate products below.


Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)

The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical hemostats and high awareness among physicians about the clinical benefits of biosurgical agents in various procedures.

This Medtech 360 Report provides high-level market metrics for biosurgical agents in Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific from 2019 through 2033

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period, with the nasal packing and myringotomy/tympanostomy device segments seeing the fastest growth rates. The market will be…
Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…
Report
Dialysis Access Treatment Devices – Market Insights – United States
The US dialysis access treatment device market will grow at a moderate rate due to the increasing adoption of innovative products, positive clinical data, and rising ASPs of specific devices like…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Neurovascular Devices – Market Insights – Europe
The European neurovascular device market is poised to experience strong growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…